Key result
Family history of heart disease is linked to ~62% higher odds of elevated hs-cTnT.
Why the study?
Family history of heart disease increases the risk of subsequent heart disease, and hs-cTnT is a recognized biomarker of myocyte injury even in individuals without heart disease. This study examined the association between family history of heart disease and elevated hs-cTnT in apparently healthy individuals.
Is a family history of heart disease associated with elevated high-sensitivity cardiac troponin T (>14 ng/L) in apparently healthy adults free of cardiovascular disease?
Cross-Sectional (n=3,821)
No
Is a family history of heart disease associated with elevated high-sensitivity cardiac troponin T (>14 ng/L) in apparently healthy adults free of cardiovascular disease?
Answers are grounded in this paper and cite their sources.
In apparently healthy individuals free of overt cardiovascular disease, a family history of heart disease—particularly when accompanied by elevated hs-CRP (>3 mg/L)—is independently associated with subclinical myocardial injury (hs-cTnT >14 ng/L).
BACKGROUND: Family history of heart disease (FH-HD) is associated with an increase drisk of subsequent HD. High sensitive cardiac troponin T (hs-cTnT) is arecognized biomarker of myocyte injury even in HD free patients. We examined the association between FH-HD and hs-cTnT in apparently healthy individuals. HYPOTHESIS: FH-HD is associated with elevated hs-cTnT in apparently healthy individuals. METHODS: In a cross sectional study we analyzed data of apparently healthy individuals (n=3,821) recruited for the Tel-Aviv Medical Center Inflammation Survey (TAMCIS). Blood samples were obtained for hs-cTnT and high sensitive CRP (hs-CRP) among other tests. FH-HD was defined as first degree family member with HD diagnosis and classified as premature if the diagnosis was done before the age of 55 for men or 65 for women. RESULTS: Elevated hs-cTnT (>14 ng/L) was more common in FH-HD of any age, and in premature FH-HD (FH-P-HD) participants than in participants without FH-HD (4.4% vs 2.0%, p<0.001 and 4.3% vs 2.0%, p=0.001, respectively). Adjustmentfor potential risk factors with association to elevated hs-cTnT (age, sex, BMI, hypertension, diabetes, hs-CRP, smoking and physical activity), showed that FH-HD and FH-P-HD remained significantly associated with elevated hs-cTnT (OR=1.62, p=0.025 and OR=1.70, p=0.039, respectively). Furthermore, we found that a significant interaction between FH-HD or FH-P-HD and high levels ofhs-CRP (>3 mg/L) increased the risk for elevated hs-cTnT (OR=3.07, p=0.036 for FH-HD and OR=3.25, p=0.053 for FH-P-HD). CONCLUSIONS: FH-HD and its interaction with elevated hs-CRP levels were significantly associated with elevated hs-cTnT in apparently healthy individuals suggesting that an inflammatory process may be involved in this association.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2019) conducted a cross-sectional in Apparently healthy individuals free of cardiovascular disease (n=3,821). Family history of heart disease (FH-HD) vs. No family history of heart disease was evaluated on Elevated high-sensitivity cardiac troponin T (hs-cTnT >14 ng/L) (OR 1.62, 95% CI 1.06-2.46, p=0.025). Family history of heart disease was independently associated with elevated hs-cTnT (>14 ng/L) in apparently healthy adults.
Synapse has enriched 10 related papers. Consider them for comparative context: